News in other languages: 1CM Inc.

04-15	Ucrania aborda el cargamento de cereales rusos "robados" en una conversación telefónica con Israel
21/10/21	Leviathan Natural Products : Israël envisage de construire un nouveau gazoduc vers l'Egypte

More news

Managers and Directors: 1CM Inc.

Manager	Title	Age	Since
Tanvi Bhandari CEO	Chief Executive Officer	-	06/03/2022
Antony Pramoth DFI	Director of Finance/CFO	-	06/01/2026

Director	Title	Age	Since
Tanvi Bhandari BRD	Director/Board Member	-	06/03/2022
Rupalee Mehta BRD	Director/Board Member	-	06/03/2022
Lucas Leone BRD	Director/Board Member	-	06/03/2022

More insiders

1CM Inc. is a Canada-based cannabis company, which is focused on cannabis and other complementary and substitutable retail industries including liquor, tobacco, and nicotine. It's One Cannabis Market is a technology platform that provides business-to-business (B2B) and business-to- consumer (B2C) Solutions, including Last Mile Delivery, Digital Signage, Big Data Analytics & Wholesale Clearing Services. Its Cost Cannabis is a brand for the urban cannabis consumer. Its Costcan Liquor includes a range of spirits, wines, beers, and other alcoholic products, expertly sourced to cater to diverse tastes and preferences. The Company is focused on expanding its operations through organic growth and by way of merger and acquisition transactions.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
16/07/26	US$0.1024	+5.39%	4,500

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets Other stock markets 17:21:38 16/07/2026 BST			5-day change	1st Jan Change
0.1024 ^USD	+5.39%		0.00%	-27.84%

04-30	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI
01-30	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2025	CI

Market Cap	14.13M 10.03M 8.81M 8.19M 7.52M 966M 14.35M 97.31M 38.02M 475M 37.66M 36.85M 1.64B	P/E 2024	57.3x	P/E 2025	57.1x
Enterprise Value	11.4M 8.09M 7.11M 6.61M 6.07M 780M 11.58M 78.51M 30.67M 383M 30.39M 29.73M 1.33B	EV / Sales 2024	0.67x	EV / Sales 2025	0.34x
Free-Float	87.24%	Yield 2024 *	-	Yield 2025	-

04-30	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026	CI
01-30	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2025	CI
01-07	1CM Inc. Announces Chief Financial Officer Changes, Effective January 7, 2026	CI
01-07	SNDL Acquires Five Cannabis Outlets From 1CM in Alberta and Saskatchewan	MT
12-30	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2025	CI
12-29	1CM Inc. Auditor Raises 'Going Concern' Doubt	CI
31/07/25	1CM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2025	CI
30/04/25	1CM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2025	CI
09/04/25	SNDL Entering Agreement to Buy Cost Cannabis and T Cannabis Locations from 1CM	MT
08/04/25	SNDL Inc. entered into an arrangement agreement to acquire 32 cannabis retail stores from 1CM Inc. for CAD 32.2 million.	CI
30/01/25	1CM Inc. Reports Earnings Results for the First Quarter Ended November 30, 2024	CI
30/12/24	1CM Inc. Reports Earnings Results for the Full Year Ended August 31, 2024	CI
29/12/24	1CM Inc. Auditor Raises 'Going Concern' Doubt	CI

05-27	1CM Provides Update on Arrangement Agreement with SNDL	NE
01-07	1CM Announces CFO Change	NE
12-15	SNDL & 1CM Provide Update Regarding Arrangement	NE
18/06/25	1CM Receives Court Approval for Arrangement with SNDL Inc	NE
16/06/25	1CM Announces Results of Shareholder Meeting	NE

1CM Inc. Share Price OTC Markets

Stocks

MILFF

CA68237A1093

Pharmaceuticals

Valuation: 1CM Inc.

Chart: 1CM Inc.

Latest news : 1CM Inc.

Press Releases: 1CM Inc.

News in other languages: 1CM Inc.

Quotes and Performance

Course Extremes

Managers and Directors: 1CM Inc.

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+5.39%
Current month	+31.11%
1 month	+31.11%
3 months	-10.72%
6 months	-22.48%
Current year	-27.84%

1 month	0.07	0.1
Current year	0.03	0.19
1 year	0.03	0.42
3 years	0.03	1.8
5 years	0.03	1.8
10 years	0	2.03

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
1CM INC.	+5.39%	0.00%	-	-	10.03M
ELI LILLY AND COMPANY	+0.86%	+1.43%	+48.50%	+160.39%	1,067B
JOHNSON & JOHNSON	+1.59%	+4.09%	+55.34%	+53.96%	635B
ABBVIE INC.	+0.95%	+1.91%	+35.91%	+81.14%	458B
ROCHE HOLDING AG	+1.60%	+6.25%	+33.95%	+29.84%	347B
NOVARTIS AG	-0.60%	+1.52%	+35.68%	+39.76%	295B
ASTRAZENECA PLC	-0.14%	+0.60%	+16.17%	+17.53%	262B
NOVO NORDISK A/S	+0.09%	-2.82%	-28.29%	-41.71%	216B
AMGEN INC.	+1.22%	+2.66%	+21.87%	+59.73%	203B
GILEAD SCIENCES, INC.	-1.18%	-3.70%	+14.23%	+66.51%	161B
Average	+0.87%	+1.33%	+25.93%	+51.91%	404.78B
Weighted average by Cap.	+0.55%	+1.95%	+35.81%	+77.68%

	2024	2025
Net sales	57.22M 40.63M 35.69M 33.19M 30.46M 3.91B 58.11M 394M 154M 1.92B 153M 149M 6.65B	73.37M 52.1M 45.76M 42.55M 39.05M 5.02B 74.5M 505M 197M 2.47B 196M 191M 8.53B
Net income	616K 437K 384K 357K 328K 42.12M 625K 4.24M 1.66M 20.71M 1.64M 1.61M 71.59M	485K 344K 302K 281K 258K 33.15M 492K 3.34M 1.3M 16.3M 1.29M 1.26M 56.36M
Net Debt	2.88M 2.04M 1.79M 1.67M 1.53M 197M 2.92M 19.82M 7.74M 96.73M 7.67M 7.5M 334M	-2.73M -1.94M -1.7M -1.58M -1.45M -187M -2.77M -18.79M -7.34M -91.74M -7.27M -7.12M -317M